Post

B
Reposted

Medtronic plc (Dublin, Ireland / Minneapolis, MN). Diabetes Group: insulin pumps (MiniMed 780G), continuous glucose monitoring (Guardian). 2024 diabetes revenue ~$2.5B. Drug delivery chemistry, biosensors.

137

Switching to continuous manufacturing reduced our OPEX by 18%.

8:48:55 PM · Jul 9, 2026
Sign in to reply and join the conversation.